Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms

EBioMedicine. 2022 Feb:76:103833. doi: 10.1016/j.ebiom.2022.103833. Epub 2022 Jan 25.

Abstract

Background: The infantile spasms syndrome is an early-onset epileptic encephalopathy presenting in the first 2 years of life, often with severe developmental consequences. The role of the gut microbiota and metabolism in infantile spasms remains unexplored.

Methods: Employing a brain injury neonatal rat model of infantile spasms intractable to anticonvulsant medication treatments, we determined how the ketogenic diet and antibiotics affected specific microbial communities and the resultant circulating factors that confer spasms protection in the infantile spasms model. To confirm a role of kynurenine metabolism pathway in spasms protection, indoleamine 2,3-dioxygenase 1 was pharmacologically inhibited and comprehensive metabolomics was applied.

Findings: We show that antibiotics reduced spasms and improved the effectiveness of the ketogenic diet when given in combination. Examination of the gut microbiota and metabolomics showed the downregulation of indoleamine 2,3-dioxygenase 1 and upregulation of hippocampal kynurenic acid, a metabolite with antiepileptic effects. To further test the involvement of indoleamine 2,3-dioxygenase 1, a specific antagonist 1-methyltryptophan and minocycline, an antibiotic and inhibitor of kynurenine formation from tryptophan, were administered, respectively. Both treatments were effective in reducing spasms and elevating hippocampal kynurenic acid. A fecal microbiota transplant experiment was then performed to examine the contribution of the gut microbiota on spasm mitigation. Transplant of feces of ketogenic diet animals into normal diet animals was effective in reducing spasms.

Interpretation: These results highlight the importance of tryptophan-kynurenine metabolism in infantile spasms and provide evidence for new-targeted therapies such as indoleamine 2,3-dioxygenase 1 inhibition or microbiota manipulation to promote kynurenic acid production as a strategy to reduce spasms in infantile spasms.

Funding: This study was funded by the Alberta Children's Hospital Research Institute and the Owerko Centre.

Keywords: Gut microbiota; Indoleamine 2,3-dioxygenase 1; Infantile spasms; Ketogenic diet.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Gastrointestinal Microbiome*
  • Humans
  • Kynurenine / metabolism
  • Kynurenine / therapeutic use
  • Rats
  • Seizures
  • Spasm
  • Spasms, Infantile* / drug therapy
  • Spasms, Infantile* / therapy
  • Tryptophan / metabolism

Substances

  • Kynurenine
  • Tryptophan